Reliability note

Titles and AI summaries are unofficial English monitoring aids, not legal advice or official translations. Each link opens the original Japanese official source, which remains authoritative.

Ministerial Ordinance amending supply assurance plan certification rules under economic security legislation

厚生労働省関係経済施策を一体的に講ずることによる安全保障の確保の推進に関する法律に基づく供給確保計画の認定等に関する省令の一部を改正する省令

Published: 2026-09-18 · Source: e-Gov Law Search — Updated Laws · Stage: In Force · Area: Labor / Employment · Impact (preliminary): Medium · First detected by this dashboard: 2026-10-07

View the original Japanese source More Labor / Employment updates Search all updates in the dashboard

AI summary

Generated by AI from the Japanese source metadata. It is an unofficial monitoring aid, not legal advice, and may contain errors. The area, stage, and impact labels are preliminary keyword-based triage labels. Confirm every point in the original Japanese source.

Summary

Ministry of Health, Labour and Welfare Ordinance No. 140 of 2026 amends the ministry's ordinance on certification and related matters for supply assurance plans under the Act on the Promotion of Ensuring National Security through Integrated Implementation of Economic Measures (Ministry of Health, Labour and Welfare Ordinance No. 8 of 2023). The listing states that the amending ordinance was promulgated and took effect on 2026-09-18; it does not describe the substantive changes.

Business Impact

Applicants for certification of supply assurance plans within the Ministry of Health, Labour and Welfare's remit may be affected by changes to the certification rules or related procedures, but the listing does not identify the specific changes or covered products.

Recommended Action

Review of the official Japanese ordinance could clarify the amended certification provisions and any transitional arrangements applying from 2026-09-18.

Reform explainer

Japan's September 2026 economic-security supply-plan rules for essential antibiotics: new cooperation-request procedure

Current stage of the reform: In force · Instrument: Ministerial Ordinance · Last verified: 2026-11-11

This AI-assisted explainer was prepared from the official sources listed below and checked against the records on this dashboard. It is a plain-English monitoring aid, not legal advice, and it is not official. Statements under Expected procedural steps describe the usual procedure, not a forecast; Outstanding uncertainties lists what was not confirmed. The original Japanese sources are authoritative.

Instruments (English names are unofficial descriptions): 2026 MHLW Ordinance No. 140 amending supply-assurance plan certification procedures (厚生労働省関係経済施策を一体的に講ずることによる安全保障の確保の推進に関する法律に基づく供給確保計画の認定等に関する省令の一部を改正する省令, 令和八年厚生労働省令第百四十号); Economic Security Promotion Act, underlying statutory scheme (経済施策を一体的に講ずることによる安全保障の確保の推進に関する法律, 令和四年法律第四十三号)

This page's record: 厚生労働省関係経済施策を一体的に講ずることによる安全保障の確保の推進に関する法律に基づく供給確保計画の認定等に関する省令の一部を改正する省令 (令和八年厚生労働省令第百四十号), amending 厚生労働省関係経済施策を一体的に講ずることによる安全保障の確保の推進に関する法律に基づく供給確保計画の認定等に関する省令 — promulgated 2026-09-18; effective date(s) recorded by e-Gov: 2026-09-18.

At a glance

What Changed?

MHLW Ordinance No. 140 was promulgated and took effect on 18 September 2026. It updates supply-assurance plan certification under Japan's Economic Security Promotion Act, including the procedure by which an approved operator may request the minister to seek third-party cooperation. [1] [2] [3]

Who Is Affected?

Businesses implementing approved supply-assurance plans for designated antimicrobial products, support agencies, counterparties asked for cooperation and MHLW officials responsible for supply security. [1] [2] [3]

What Should Businesses Do Now?

If an accredited supply-assurance project faces obstacles that warrant support from related parties, review amended Article 8-2 and Form 12-2 and whether a request to MHLW is appropriate. Do not assume this creates a general mandatory cooperation duty for every supplier. [1] [2] [3]

Background & Purpose

The Economic Security Promotion Act identifies certain products as especially important to national supply resilience. MHLW explains that beta-lactam antimicrobial products rely heavily on imported starting materials, and that a 2019 cefazolin supply disruption originating in overseas manufacturing problems seriously affected Japanese medical care. It supports domestic active-ingredient manufacturing and reserves to manage interruption risk. These facts explain the supply-security programme; the ordinance change is an implementation rule within that programme, not a general new medicines-licensing system.

Approved plans under the Economic Security Promotion Act set out supply assurance investments, inventories, demand-surge measures and other qualifying activities. MHLW's regulation specifies plan applications, examination, ongoing compliance, reporting and associated forms. As amended, Article 8-2 provides that an accredited operator invoking Act Article 11-2(1), which provides a route to ask the authority to seek cooperation from related parties, must submit Form 12-2 to the Minister of Health, Labour and Welfare. This is an application procedure for eligible certified operators rather than an unconditional obligation to make a request.

The revised rule also defines measures for securing supply during a shortage, including handling priority supply and intended uses, increasing production or releasing reserves, considering substitutes and diversified procurement, and investment in supply capacity. These matters affect how supply plans are examined and implemented. The regulation does not itself guarantee support approval, impose supply obligations on unrelated companies, or prove that every antimicrobial product is a designated strategic item.

Sources: [1] [2] [3]

Legislative & Regulatory History

Japan enacted the Economic Security Promotion Act as Act No. 43 of 2022. Antimicrobial products became a designated important product under its implementing framework, and MHLW established an assurance programme with plan certifications and support for selected producers. The ministry's policy is to strengthen domestic production and reserves to secure critical beta-lactam antibiotic availability by 2030; this is a policy objective, not a new statutory deadline binding all manufacturers.

MHLW opened public consultation 495260150 on 24 August 2026 and accepted submissions through 4 September 2026 at 18:00 Japan time. Because timely supply-security implementation was needed alongside the 2026 Economic Security Promotion Act/JBIC reform, the ministry cited Administrative Procedure Act Article 40(1) for a shorter-than-usual comment period.

On 18 September 2026, MHLW promulgated Ordinance No. 140, which e-Gov records as effective on the same day. The enacted text now provides the cooperation-request form, alongside existing and amended measures for certified supply plans. It should be distinguished from separate METI rules and joint MHLW/METI ordinances even though they implement related Economic Security Promotion Act provisions.

  1. 2026-08-24 — MHLW consultation 495260150 opened [2]
  2. 2026-09-04 — Public comment closed at 18:00 JST [2]
  3. 2026-09-18 — Amended supply-plan procedures effective [1]
  4. 2026-09-18 — Ordinance No. 140 promulgated [1]

The timeline of related official records below lists the records this dashboard has matched.

Sources: [1] [2] [3]

What Happens Next

Confirmed next steps

  • 2026-09-18 — MHLW Ordinance No. 140 was promulgated and took effect according to e-Gov Law Search. [1]
  • 2026-09-04 — Public consultation 495260150 closed at 18:00 Japan time; it is no longer open. [2]

Expected procedural steps

The usual procedure for this kind of instrument; not a forecast for this reform.

  • Approved antimicrobial supply-plan operators facing serious implementation obstacles may assess whether to use the Article 11-2(1) request route and submit Form 12-2 in accordance with Article 8-2, supported by evidence of the supply-security problem.
  • MHLW will continue supervising certifications and plan implementation under the existing statutory scheme, including assessments of shortages, supply resilience and reporting. These are operational expectations, not guarantees that an authority will secure cooperation.

Outstanding uncertainties

  • Whether a particular undertaking qualifies as an approved supply-assurance operator and which other parties may be asked for cooperation must be assessed case by case under the certification and statutory provisions.
  • The legal effect of ministerial requests toward individual third parties, the form and limits of support, and any related investment subsidy terms cannot be assumed solely from the existence of Form 12-2.
  • The actual cost and lead time of domestic production and stockpiling investments will differ by product and certified plan; the policy's 2030 objective is not a uniform corporate deadline.

Business Impact & Practical Considerations

Accredited antimicrobial manufacturers should integrate the amended request procedure into contingency plans, keep records of bottlenecks, inventory and logistics, and distinguish ordinary periodic reporting from requests for the Minister to approach related parties. Operators without approved plans do not automatically gain the specific statutory request right merely because they sell pharmaceuticals.

Manufacturers, medical supply-chain partners and support institutions can use the established MHLW programme to evaluate accredited projects and resilience investments. Government support and cooperation are subject to the statutory criteria and individual approvals, and should not be booked as unconditional entitlements. A general pharmaceutical compliance change should not be inferred from a targeted economic-security measure.

Points to check

  • Identify whether the business holds an MHLW-approved supply-assurance plan for a designated antimicrobial product and review the plan's existing conditions.
  • Where cooperation from other participants is needed, check Act Article 11-2(1), MHLW Ordinance Article 8-2 and Form 12-2 before preparing a documented request.
  • Review shortage-response and diversification measures, inventory, production and permitted changes to approved plans; preserve current reporting duties.
  • Confirm details with current MHLW guidance and the e-Gov enacted ordinance effective 18 September 2026; do not rely solely on the earlier draft or presume a blanket duty for suppliers.

Sources: [1] [2] [3]

Official sources

  1. Current MHLW supply-plan certification ordinance, 18 September 2026 amendment, Article 8-2 and Form 12-2 — e-Gov Law Search; accessed 2026-11-11
  2. Consultation 495260150: amendment of supply-assurance certification ordinance, 24 August 2026 — MHLW / e-Gov Public Comment; accessed 2026-11-11
  3. Economic Security Promotion Act programme for stable supply of antimicrobial products, background, certification and support — Ministry of Health, Labour and Welfare; accessed 2026-11-11

Timeline of related official records

Related official records are linked only when names and instrument numbers match exactly, so this timeline may be incomplete. Dates are as stated by the official sources. It is a monitoring aid, not legal advice; the original Japanese sources are authoritative.

  1. 2026-08-24 — Draft published for public comment (e-Gov) 「厚生労働省関係経済施策を一体的に講ずることによる安全保障の確保の推進に関する法律に基づく供給確保計画の認定等に関する省令の一部を改正する省令案」に関する御意見の募集について Dashboard page Original Japanese source
  2. 2026-09-04 — Public comment deadline (2026-09-04 18:00 JST) Dashboard page Original Japanese source
  3. 2026-09-18 — Promulgated (instrument recorded by e-Gov Law Search) 厚生労働省関係経済施策を一体的に講ずることによる安全保障の確保の推進に関する法律に基づく供給確保計画の認定等に関する省令の一部を改正する省令(令和八年厚生労働省令第百四十号) (this update) Original Japanese source
  4. 2026-09-18 — Effective date stated by e-Gov Law Search 厚生労働省関係経済施策を一体的に講ずることによる安全保障の確保の推進に関する法律に基づく供給確保計画の認定等に関する省令 (this update) Original Japanese source